Catalyst Wire Dossier Catalyst Wire Dossier

SST-0225 7.5% ibuprofen cream

ibuprofen · Strategic Science & Technologies, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SST-0225 7.5% ibuprofen cream, covering 2014-01-27 to 2014-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label, Maximum-Dose Pharmacokinetic Study of 7.5% Ibuprofen Cream (SST-0225) in Healthy Adults [Phase 1]

See pricing